BZAR
BZAR (Rhodamine 110, bis-(N-CBZ-L-arginine amide), dihydrochloride) is a substrate for serine proteases (1-5) and is also an inhibitor for quanidinobenzoatase. It is 50 to 100 times more sensitive than the AMC-based substrate.
This product is available by special order only.
Please fill in the inquiry form and we will contact you shortly.
Please fill in the inquiry form and we will contact you shortly.
Wishlist updated! View wishlist
Product Description
BZAR (Rhodamine 110, bis-(N-CBZ-L-arginine amide), dihydrochloride) is a substrate for serine proteases (1-5) and is also an inhibitor for quanidinobenzoatase. It is 50 to 100 times more sensitive than the AMC-based substrate.
- λExλEmof end product (R110) = 496/520 nm
- Off-white to pink solid soluble in DMSO
- Store at 4°C and protect from light
- C48H52Cl2N10O9
- MW: 983.91
References
1. J Histochem Cytochem 49, 1473(2001).
2. Biotechniques 29, 1108-1113 (2000).
3. J Enzyme Inhib 6, 303(1992).
4. Biochem Soc Trans 18, 632 (1990).
5. J Cancer Res Clin Oncol 116, 57 (1990).
6. J Enzyme Inhib 2, 209 (1988).
You may also like…
Dual Apoptosis Assay with NucView® 488 Caspase-3 Substrate & Annexin V
These kits provides two apoptosis markers, our novel NucView® 488 Caspase-3 Substrate and Annexin V conjugate for detecting caspase-3 activation and phosphatidylserine (PS) translocation.
Staurosporine
Staurosporine is a potent and cell-permeable inhibitor of a wide variety of protein kinases by competing for the ATP binding site.